Cybersecurity in eQMS directly affects your ability to demonstrate compliance, protect intellectual property, and maintain operational continuity. Weaknesses don’t stay contained. They surface in audits, submissions, and customer trust.
Your eQMS holds some of your most sensitive assets: design history files, risk management documentation, clinical data, supplier records, and audit trails.
A breach doesn’t just mean data loss. It can trigger regulatory findings, delay approvals, and undermine trust with notified bodies and customers.
Yet many teams still evaluate eQMS platforms primarily on functionality and compliance features, overlooking cybersecurity until IT raises a red flag late in the process.
That gap in evaluation can become a material risk.
This article outlines the key cybersecurity questions regulated companies (especially scaling medical device firms) should be asking eQMS vendors before making a decision.
Medical device companies operate in a uniquely high-stakes environment, where the security of systems like the eQMS has direct regulatory and commercial consequences.
Standards such as ISO 13485 and the FDA Quality Management System Regulation (QMSR), which, since February 2026, has incorporated ISO 13485:2016 by reference, require rigorous control over documentation and records. In FDA-regulated settings, 21 CFR Part 11 adds specific controls over electronic records and signatures, including secure, time-stamped audit trails and limits on system access. If your eQMS is compromised, the integrity of your audit trail (and therefore your ability to demonstrate compliance) can be called into question.
At the same time, the system holds valuable intellectual property. Design files and technical documentation are obvious targets, particularly for organisations operating in competitive or highly innovative markets.
There is also a clear operational dependency. If your eQMS becomes unavailable, document release, CAPA management, and audit preparation can quickly grind to a halt.
This is one of the most fundamental questions in eQMS cybersecurity, yet it’s often answered at a frustratingly high level.
You need clear, specific information on:
A strong answer will be precise and transparent, referencing named infrastructure providers, defined regions, and least-privilege access policies for vendor staff.
A red flag is any vague reference to “secure servers” or an inability to clearly explain how access is governed.
Certifications provide independent validation of a vendor’s security practices, but only if you look beyond the surface.
ISO 27001, in its current 2022 edition, should be considered a baseline. It demonstrates that the vendor operates a structured, audited information security management system.
Beyond that, it’s worth asking about:
Crucially, don’t rely on marketing claims. Ask for the actual certificates, confirm they are current, and check the scope. A certification that excludes key parts of the platform offers limited reassurance.
Encryption is a foundational layer of eQMS cybersecurity, but it needs to be implemented correctly to be meaningful.
At a minimum, you should expect:
It’s also worth understanding who controls the encryption keys and whether more advanced options (such as customer-managed keys) are available.
Encryption at rest protects against storage-level compromise, while encryption in transit protects data moving between users and the system. Both are essential.
Access control sits at the intersection of cybersecurity and regulatory compliance.
Your eQMS should support:
In regulated environments, you need to be able to show auditors exactly who had access to specific records, and what actions they were authorised to take.
Every vendor will claim to take security seriously. Their incident response process is where that claim is tested.
You should ask for:
A good vendor will also be able to describe how incidents are reviewed and what changes are implemented afterwards.
If the answer stays at the level of “we follow best practices,” that’s a sign the process may not be as mature as it should be.
Your eQMS vendor doesn’t operate in isolation. Their infrastructure depends on a network of third-party providers, each introducing potential risk.
You should expect:
This is directly analogous to supplier quality management in your own organisation. If you’re expected to control your supply chain, your vendors should be doing the same.
A secure eQMS is one that evolves continuously. But in regulated environments, change must be controlled.
Key areas to explore include:
This last point is particularly important. For medical device manufacturers, uncontrolled changes can invalidate system validation, creating compliance risk. A strong vendor will understand this tension and provide documentation or processes to support ongoing validation.
Cybersecurity is also about ensuring resilience when things go wrong.
You should request:
eQMS downtime has real consequences. It can delay audits, block document approvals, and disrupt regulatory submissions at critical moments.
Checklists are useful, but they only tell you what a vendor claims to do. Security culture is reflected in how those claims are communicated, supported, and upheld over time.
A few signals are worth paying close attention to:
Does the vendor openly document their security approach through a trust centre, security whitepaper, or detailed policies? More importantly, do they communicate proactively about vulnerabilities and incidents, or only when pressed? Vendors that treat cybersecurity as a core part of their value proposition tend to be far more forthcoming than those that see it as a risk to manage quietly.
The procurement process is often your clearest window into how a vendor operates under scrutiny. When you ask detailed cybersecurity questions, do you get clear, specific answers, or deflection? Phrases like “our IT team handles that” or overly polished reassurance without substance are warning signs. Strong vendors engage directly and comfortably with technical detail.
Security commitments should be visible in the contract, not implied. Review the Data Processing Agreement (DPA) and Master Services Agreement (MSA) carefully. Look for clearly defined breach notification obligations, data protection responsibilities, and liability terms that reflect the real-world impact of a security incident. Vague language here often signals gaps elsewhere.
Finally, validate what you’ve been told. Ask for references specifically within medical device or other regulated industries, where expectations around eQMS cybersecurity are higher. When speaking to them, go beyond general satisfaction. Ask whether they’ve encountered security concerns and how the vendor responded. That’s where maturity becomes visible.
When cybersecurity is built into an eQMS from the outset (not retrofitted), you typically see:
This alignment is critical for scaling medical device companies, where systems must support both compliance and speed.
Cognidox is designed specifically for regulated industries such as medical devices and high-tech product development, where eQMS cybersecurity and compliance are tightly linked.
Its approach reflects many of the principles outlined above:
This has enabled companies to scale while maintaining strong governance.
When evaluating any eQMS provider, use this as a baseline:
|
Area |
What to Ask For |
|
Hosting & Infrastructure |
Cloud provider, data residency, tenancy model |
|
Certifications |
ISO 27001, SOC 2 Type II, pen test reports |
|
Encryption |
AES-256 at rest, TLS 1.2+ in transit, key management |
|
Access Controls |
RBAC, MFA enforcement, SSO support, session policies |
|
Incident Response |
IR plan, breach notification SLAs, named security contact |
|
Third-Party Risk |
Subprocessor list, supplier assessment process |
|
Secure Development |
SDLC practices, patching SLAs, validation support |
|
Business Continuity |
RTO/RPO, backup testing, uptime SLAs, geo-redundancy |
None of these questions should catch a good vendor off guard. If they do, that tells you something important.
For medical device manufacturers, the eQMS is not peripheral infrastructure. It’s the system that holds your quality records, your audit trail, and ultimately your evidence of compliance.
That means cybersecurity in eQMS is not a separate technical consideration. It’s part of how you maintain control over your quality system.
The mechanics of evaluation are straightforward: ask the right questions, expect specific answers, and verify what you’re told. Where organisations fall short is not in knowing what to ask, but in accepting incomplete or untested responses.
Vendors who operate in regulated environments should be able to demonstrate their security posture clearly, consistently, and without hesitation.
Cognidox is built for that context. It supports the document control, auditability, and validation requirements that medical device and high-tech companies rely on, with security practices aligned to those expectations.
Cybersecurity in eQMS is critical because the system stores regulated data, including design history files, CAPA records, and audit trails. A security breach can compromise the integrity of this data, leading to failed audits, delayed regulatory approvals, and potential loss of intellectual property. For medical device companies, this makes eQMS cybersecurity a core part of compliance, not just an IT concern.
A secure eQMS should include role-based access control (RBAC), multi-factor authentication (MFA), encryption (both at rest and in transit), and immutable audit trails. It should also support secure hosting environments, regular backups, and a clearly defined incident response process. These features ensure both data protection and compliance with standards such as ISO 13485 and FDA 21 CFR Part 11.
To assess eQMS cybersecurity, ask vendors for specific, verifiable details about their infrastructure, certifications (such as ISO 27001), access controls, and incident response processes. You should also review their Data Processing Agreement, understand how they manage third-party risk, and speak to reference customers in regulated industries. Strong vendors will provide clear, detailed answers and supporting evidence without hesitation.